Stocks
Amgen AMGN
Health care sectorNasdaq
- Close
- $423.68
- 09/29 close
- Day change
- +1.3%
- vs previous close
- Volume
- 134,770
- −17.7% vs 30-day average
- 52-week range
- $271.02$446.99
- 1-year return
- +54.6%
- vs the close a year ago
- Market cap
- $229.1B
- 540,632,005 shares · reported 07/30
Company
- Exchange
- Nasdaq
- Sector
- Health care
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Thousand Oaks, California
- Fiscal year end
- 12/31
- Next earnings
- 11/03, estimated
Members of Congress reported 5 trades in Amgen AMGN in the past 90 days (0 purchases, 5 sales).
- Dividendquarterly
- $2.52 a share
- Ex-dividend 08/21 · trailing yield 1.19% (2 dividends in 12 months over the 09/29 close)
Price
$423.68Day +1.3%1 year +54.6%
26-week trading
Common questions
- Which members of Congress traded Amgen AMGN recently?
- The latest reported trades: Rep. David Taylor, full sale on 08/26 (reported 09/05), Sen. Sheldon Whitehouse, partial sale on 08/12 (reported 09/02), Sen. Tommy Tuberville, full sale on 25/04/15 (reported 08/05) and Sen. Alan Armstrong, full sale on 03/27 (reported 07/21).